Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes (Liratime)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01499108
Recruitment Status : Completed
First Posted : December 26, 2011
Last Update Posted : February 2, 2015
Novo Nordisk A/S
Information provided by (Responsible Party):
Peter Rossing, Steno Diabetes Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2013
  Study Completion Date : August 2014